The main purpose of this study was to investigate the barriers to and facilitators of licensing, credentialing, and insurance reimbursement for SUD treatment providers across the nation.
Biomedical Research, Science, & Technology
Discover research in the areas of Biomedical Innovation, Electronic Health Records, Information Technology, and Medical Product Development.
Noteworthy
Reports
Displaying 61 - 70 of 233. 10 per page. Page 7.
Advanced SearchCredentialing, Licensing and Reimbursement of the SUD Workforce: A Review of Policies and Practices Across the Nation
The main purpose of this study was to investigate the barriers to and facilitators of licensing, credentialing, and insurance reimbursement for substance use disorder (SUD) treatment providers across the nation.
CREDENTIALING, LICENSING, AND REIMBURSEMENT OF THE SUD WORKFORCE: A REVIEW OF POLICIES AND PRACTICES ACROSS THE NATION
CREDENTIALING, LICENSING, AND REIMBURSEMENT OF THE SUD WORKFORCE: A REVIEW OF POLICIES AND PRACTICES ACROSS THE NATION Nilufer Isvan, Rachael Gerber, David Hughes, Kristin Battis, and Evan Anderson Human Services Research Institute John O'Brien
Impact of Participation in Technology-Enabled Collaborative Learning and Capacity Building (ECHO) Models on Provider Retention
This analysis, which used data on participation in Project ECHO provided by New Mexico’s ECHO Institute, explored two retention-related hypotheses: Participation in an ECHO intervention results in increased provider retention at the individual practitioner level; and
ASPE Data Point
Current Estimates of Supply and Utilization of Immune Globulin Products
In February 2007, the Eastern Research Group (ERG) submitted to the Office of the Assistant Secretary for Planning and Evaluation (ASPE) Analysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IG
Report to Congress
Report to Congress: Current State of Technology-Enabled Collaborative Learning and Capacity Building Models
This report responds to the December 2016 “Expanding Capacity for Health Outcomes (ECHO) Act,” Public Law 114-270, which requires the Department to report to Congress on a range of issues related to technology-enabled collaborative learning and capacity building models and make recommendations on their use. This report consists of a summary document that includes the Department’s recommen
Perspectives of Physicians in Small Rural Practices on the Medicare Quality Payment Program
The objectives of this research effort were to collect feedback through interviews with physicians in small rural practices on the initial implementation of Medicare’s Quality Payment Program in 2017, a new value-based purchasing program for Medicare physicians.
Economic Incentives for the Development of Rapid Point-of-Care (POC) Diagnostic Devices for C.Difficile, Carbapenem-Resistant Enterobacteriaceae (CRE), and Neisseria Gonorrhoeae
Antibacterial resistance is responsible for excess morbidity, mortality, and medical costs around the globe. Estimates vary widely, but the economic cost of antibacterial resistance in the United States could be as high as $20 billion and $35 billion a year in excess direct healthcare costs and lost productivity costs, respectively. CDC’s most recent report on U.S.
National Action Plan for Combating Antibiotic-Resistant Bacteria Progress Report: Year 3
Antibiotic Resistance continues to pose a significant threat to our Nation’s public health. To coordinate and enhance the public health response to this threat, the U.S. Government developed the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB). The CARB Task Force is co-chaired by HHS, USDA, and DOD.
Cost Drivers in the Development and Validation of Biomarkers Used in Drug Development
Despite the increasing investment and interest in drug development, the amount of time and resources needed to develop a new drug continues to rise. Biomarkers are an important tool with the potential to decrease the time, cost, and failure rate of drug development.